Temporary circulatory assistance by impella ™ in interventional cardiology: observational study and medico-economic assessment after four years of use
Conclusions : The Impella™ is of clinical interest under very specific conditions. Its high cost and the absence of inclusion on the list of reimbursements in addition to Homogeneous Groups of Stays represent a significant financial burden for health care establishments. Thus, optimizing the rating of future stays is a necessity.PMID:37923010 | DOI:10.1016/j.pharma.2023.10.012
Source: Annales Pharmaceutiques Francaises - Category: Drugs & Pharmacology Authors: Bouillot Elodie Cherpin Am élie Remacle Bonnet Anne Bonello Laurent Peyron Florence Source Type: research
More News: Angioplasty | Cardiogenic Shock | Cardiology | Coronary Angioplasty | Drugs & Pharmacology | Emergency Medicine | Health Management | Heart | Medical Devices | Pharmaceuticals | Study